Minimally Invasive Spine Surgery (MISS) of the lumbar spine is a type of surgery that uses smaller incisions that standard lumbar spine surgery. Minimally Invasive Spine Surgery can result in less pain, faster recovery, and less damage to nearby muscles and tissue. The advent of interactive navigation and intraoperative imaging have become an important part of accurate, efficient, and safe spine surgery using minimally invasive techniques.

Presenters:

Michael McDermott, M.D., Chief Medical Executive at Baptist Health Miami Neuroscience Institute and the Irma & Kalman Bass Endowed Chair in Clinical Neuroscience

Michael Gomez, M.D., Spinal Neurosurgeon and Director of Minimally Invasive Spine Surgery at Baptist Health Miami Neuroscience Institute at South Miami Hospital.

Inappropriate sinus tachycardia, also known as IST, is a condition of elevated sinus rate unassociated with known pathological, pharmacological, or physiological causes. Its diagnosis has been, in the past, missed or at times dismissed. It does not help that its definitions in current literature are inconsistent, and professional society consensus have had limited impact. Considering its broad setting of physiology, pathology, and uncertainties, the therapy for IST remains challenging. To date high rates of symptom recurrence, treatment failure, and complications have followed many therapies.

Although, not well accepted by guidelines, the main hope lies in ablation procedures. Unfortunately, the results of endocardial radiofrequency ablation have not been encouraging. Today we will explore the multiple aspects of IST and the treatment techniques surrounding it.

Presenters:

Steven Hoff, M.D., a board-certified cardiac and thoracic surgeon at Baptist Health Miami Cardiac & Vascular Institute

Mario Pascual, M.D., an electrophysiologist with Baptist Health Miami Cardiac & Vascular Institute specializing in diagnosing arrhythmias and treating heart rhythm disorders

We could not be more exhilarated about the research led by investigators at Baptist Health Miami Cancer Institute. Several of our physician-researchers presented their studies at this year’s ASCO annual meeting in Chicago. Join us as we highlight many of our findings, because many of these landmark studies are transforming care, extending lives, and improving the quality of life of our patients.

Presenters:

Michael Zinner, M.D., Executive Medical Director of Baptist Health Miami Cancer Institute

Manmeet Ahluwalia, M.D., Chief of Medical Oncology, Chief Scientific Officer, Deputy Director of Miami Cancer Institute, and Fernandez Family Foundation Endowed Chair in Cancer Research

Even with the success of reducing smoking, lung cancer remains the leading cause of cancer deaths worldwide for both men and women. In 2023, there were approximately 238,000 new lung cancers and 125,000 deaths in the United States alone. In recent decades, the evolution of robotic-assisted thoracic surgery has enhanced primary lung cancer treatment and postoperative outcomes. This, in combination with advances in immunotherapy and our understanding of cancer’s molecular biology, brings many tools to the battle against the leading cause of cancer deaths in the United States.

Join Dr. Mark Dylewski, chief of general thoracic surgery at Baptist Health, and Dr. Paul Kaywin, medical oncologist at Baptist Health Miami Cancer Institute, as they discuss advances in lung cancer treatment from a medical oncology and surgical perspective.

Mark Dylewski, M.D.

Director of General Thoracic Surgery and Robotic Thoracic Surgery

Chief of General Thoracic Surgery, Baptist Health

Chairman of Thoracic Surgical Oncology, Miami Cancer Institute

Paul Kaywin, M.D.

Medical Oncologist

Miami Cancer Institute

Baptist Health

Join Drs. Michael McDermott and Nir Lipsman as they discuss focused ultrasound in neuroscience, how it started and the clinical research that brings us to where we are today and what the future holds.

Presenters:

Michael McDermott, M.D.

Chief Medical Executive, Baptist Health Miami Neuroscience Institute
Irma & Kalman Bass Endowed Chair in Clinical Neuroscience

Nir Lipsman, M.D.

Harquail Chair in Neuromodulation, University of Toronto and Sunnybrook Health Sciences Centre

Director, Harquail Centre for Neuromodulation, Sunnybrook

Michael McDermott, M.D., is a neurosurgeon and the chief medical executive of Baptist Health Miami Neuroscience Institute. He is a world-renowned leader in neurosciences and has clinical expertise in the field of meningioma surgery and Gamma Knife radiosurgery.

Nir Lipsman, M.D., is a neurosurgeon, scientist and Director of Harquail Centre for Neuromodulation at Sunnybrook and associate professor in the department of surgery at the University of Toronto. Dr. Lipsman helped lead Canada’s first clinical trials of FUS in essential tremor and Parkinson’s disease, and is developing trials investigating FUS in obsessive-compulsive disorder, depression, and Alzheimer’s disease.

In the third and final episode of the series on atrial fibrillation with Dr. Steven Hoff and Dr. Mario Pascual, we will examine the advancements in left atrial appendage management and discuss what lies ahead in promising developments offering brilliant and never-imagined solutions.

Presenters:

Steven Hoff, M.D., a board-certified cardiac and thoracic surgeon at Baptist Health Miami Cardiac & Vascular Institute. Dr. Hoff specializes in adult cardiac surgery.

Mario Pascual, M.D., electrophysiologist with Baptist Health Miami Cardiac & Vascular Institute. He focuses on the heart’s electrical system and specializes in diagnosing and treating heart rhythm disorders, or arrhythmias.

Join Michael McDermott, M.D., chief medical executive of Baptist Health Miami Neuroscience Institute, and Irma & Kalman Bass Endowed Chair in Clinical Neuroscience, along with Manmeet Ahluwalia, M.D., MBA, FASCO, the chief of medical oncology, chief scientific officer & deputy director, and Fernandez Family Endowed Chair in Cancer Research at Baptist Health Miami Cancer Institute, as they discuss a prospective clinical trial on the use of low intensity focused ultrasound for non-small cell lung cancer brain metastases, gender distribution, previous treatment results, and overall survival.

Presenters

Michael McDermott, M.D.

Chief Medical Executive, Miami Neuroscience Institute

Irma & Kalman Bass Endowed Chair in Clinical Neuroscience

Manmeet Ahluwalia, M.D., MBA, FASCO

Chief of Medical Oncology, Chief Scientific Officer & Deputy Director,

Fernandez Family Endowed Chair in Cancer Research

Baptist Health Miami Cancer Institute

Join Tom C. Nguyen, M.D., chief medical executive, director of minimally invasive valve surgery of Baptist Health Miami Cardiac & Vascular Institute, and Barry T. Katzen Endowed Chair, along with Nish Patel, M.D., an interventional cardiologist and Director of the Structural Heart Program at Baptist Health Miami Cardiac & Vascular Institute, as they discuss the future of AI in modern-day medicine and within the field of Cardiology and Cardiothoracic Surgery.

This episode explores AI innovation and how it’s becoming an essential medical tool in modern-day medicine. Join us as we explore how AI has assisted in becoming a promising tool for practicing physicians in surgery, research, the importance of staying current on all new technologies, and how we can incorporate them into our daily practices, which gives medicine the promise to save and enhance countless lives not only in our community but on a global scale.

Tom C. Nguyen, M.D., Chief Medical Executive, Barry T. Katzen Medical Director Endowed Chair and Director of Minimally Invasive Valve Surgery at Baptist Health Miami Cardiac & Vascular Institute

Nish Patel, M.D., Director, Structural Heart Program at Baptist Health Miami Cardiac & Vascular Institute